Status: Recruiting
The REValve Clinical Trial an Evaluation Of the ReValve Palmetto Valve for the Replacement of the Native Mitral VaLVE
An evaluation of the ReValve System for treatment of clinically significant mitral regurgitation in subjects determined appropriate for mitral valve surgery.
Participants needed: 20
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: ReValve Solutions Inc.Updated: Jul 29, 2026Locations: 3
Eligibility criteria
Symptomatic MR (≥3+) due to ischemic and non-ischemic cardiomyopathy etiology de... [+4]
Untreated clinically significant coronary artery disease requiring revasculariza... [+7]